MSD
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MSD
New Pink Sheet PRIME Tracker Reveals The Companies With The Most Entries On EMA Scheme
Securing a place on the European Medicines Agency’s priority medicines scheme is not easy, but some companies have managed to make the grade more than once.
AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU
The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.
Pharma Cash Keeps Flowing Into Ireland
MSD and Astellas have joined Lilly, Takeda and AstraZeneca in making major investments in Ireland this year.
Roche’s Seven-Minute Tecentriq Jab Wins First Ever Regulatory Approval
The National Health Service in England says it will be the first health system in the world to roll out a subcutaneously administered formulation of Tecentriq, after the UK MHRA became the first drug regulator to approve the product.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Merck Sharpe & Dome
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice